Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Remimazolam in Kidney Transplant Recipients
NCT07045467Phase 1Recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Jul 2025
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of remimazolam, sponsored by Shandong Provincial Qianfoshan Hospital. Primary endpoints: Remimazolam Plasma Concentration, Remimazolam Pharmacokinetic Parameters and 5 more. Started Jul 2025; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT07045467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07045467.